Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Chronic Inflammatory Demyelinating Polyradiculoneuropathy clinical trials recruiting in the U.S.
17 studies for Chronic Inflammatory Demyelinating Polyradiculoneuropathy are recruiting participants at sites across the United States.
Cities with the most studies
- New York City, NY7 studies
- Houston, TX6 studies
- Miami, FL5 studies
- St. Louis, MO5 studies
- Indio, CA5 studies
- Washington, DC5 studies
- Philadelphia, PA5 studies
- Tampa, FL4 studies
- New Haven, CT4 studies
- Kansas City, KS4 studies
- San Francisco, CA4 studies
- Orlando, FL4 studies
- Birmingham, AL4 studies
- Melbourne, FL3 studies
- Raleigh, NC3 studies
- Milwaukee, WI3 studies
- Scottsdale, AZ3 studies
- Cleveland, OH3 studies
- Portland, OR3 studies
- Cincinnati, OH3 studies
- Seattle, WA3 studies
- Boston, MA3 studies
- Tucson, AZ3 studies
By state
- Alabama4 studies
- Arizona6 studies
- California11 studies
- Colorado4 studies
- Connecticut6 studies
- District of Columbia5 studies
- Florida10 studies
- Illinois4 studies
- Kansas4 studies
- Louisiana3 studies
- Massachusetts4 studies
- Michigan5 studies
- Missouri3 studies
- New York7 studies
- North Carolina7 studies
- Ohio6 studies
- Oregon3 studies
- Pennsylvania6 studies
- Tennessee4 studies
- Texas8 studies
- Washington3 studies
- Wisconsin3 studies
Recently updated studies
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07032662A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07540221A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07091630A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT06752356Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07264426A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT06798012A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT06920004A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Oct 28, 2026 · NCT06858579A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT06680037Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Oct 19, 2026 · NCT07304154A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 19, 2026 · NCT06290141Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 24, 2026 · NCT06968975A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
RecruitingObservational study
All ages · Women · Updated Feb 17, 2026 · NCT06299748A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jan 20, 2026 · NCT06747351IVIG vs SCIG in CIDP
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Dec 11, 2025 · NCT05584631A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 21, 2025 · NCT06538064Biorepository and Registry for Plasma Exchange Patients
RecruitingObservational study
Ages 12 to 99 · All sexes · Updated May 20, 2025 · NCT05004493From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.